share_log

Stocks of the Hour: 88 Energy, Auric Mining, LBT Innovations

Stocks of the Hour: 88 Energy, Auric Mining, LBT Innovations

當下股票:88 能源、Auric Mining、LBT Innovations
sharecafe ·  02/22 09:10

To register for Friday's webinar click here.

要註冊參加週五的網絡研討會,請單擊此處。

88 Energy (ASX:88E, AIM:88E, OTC:EEENF) announced the successful WI Transfer by Monitor Exploration Limited to 88 Energy in relation to Petroleum Exploration Licence 93, located in the Owambo Basin, Republic of Namibia following receipt of the approval of the Ministry of Mines and Energy. The stage 1 consideration is US$0.7 million, with a carry of up to US$3.0 million of 2024 work program. Shares are trading 30 per cent higher at 0.65 cents.

88 Energy(澳大利亞證券交易所股票代碼:88E,AIM: 88E,場外交易代碼:EEENF)宣佈,在獲得礦業和能源部的批准後,Monitor Exploration Limited成功向88 Energy轉讓了位於納米比亞共和國奧萬博盆地的93號石油勘探許可證。第一階段的對價爲70萬美元,2024年工作計劃的餘額高達300萬美元。股價上漲30%,至0.65美分。

Auric Mining (ASX:AWJ) announced that Stage Two of mining of the Jeffreys Find Gold Mine near Norseman, WA, will commence in the week starting 4 March 2024 with the intention to extract a minimum of 300,000 tonnes of ore. There will be multiple processing campaigns throughout the year for Stage Two of the Project with BML Ventures Pty Ltd contracted to put the first parcel through the Mill in April 2024. Shares are trading 8.7 per cent higher at 12.5 cents.

Auric Mining(澳大利亞證券交易所股票代碼:AWJ)宣佈,華盛頓州諾斯曼附近的傑弗里斯·芬德金礦的第二階段開採將在2024年3月4日開始的一週內開始,旨在開採至少30萬噸礦石。該項目的第二階段全年將開展多項加工活動,BML Ventures Pty Ltd簽訂了合同,將第一批包裹於2024年4月通過工廠。股價上漲8.7%,至12.5美分。

Australian medical technology company LBT Innovations Limited (ASX:LBT), a leader in medical technology automation using artificial intelligence, has announced the delivery of APAS PharmaQC to Thermo Fisher Scientific, Inc (Thermo Fisher). Shares are trading 15.38 per cent higher at 1.5 cents.

澳大利亞醫療技術公司LBT Innovations Limited(澳大利亞證券交易所股票代碼:LBT)是使用人工智能的醫療技術自動化領域的領導者,該公司宣佈向賽默飛世爾科學公司(Thermo Fisher)交付APAS PharmaQC。股價上漲15.38%,至1.5美分。

1x1.png?futu_img_keep_extra_domain=1

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論